“Global Surgical Sutures market set to grow to $6.4bn by 2024” says new Visiongain report

08 October 2019
Pharma

Visiongain has published a new pharma report Global Surgical Sutures Market 2020-2030: Absorbable Sutures, Non-Absorbable Sutures, Automated Suturing Devices, General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Gynaecological Surgery, Ophthalmic Surgery, Facial, Cosmetic & Plastic Surgery.

The global surgical sutures market is expected to reach $6.4bn in 2024 and is estimated to grow at a CAGR of 5.1% from 2019-2024. The Absorbable Sutures submarket held 52% of the global surgical sutures market in 2019.The global anaesthesia drugs market is projected to grow at lucrative rate during the forecast period owing to a rising number of surgical procedures globally, developing healthcare infrastructure in emerging economies, and growing number of geriatric population.

This report profiled the selected companies: AD Surgical, B. Braun Melsungen AG, Bioline Fios Cirúrgicos Ltda, CP Medical, DemeTech Corporation, Ethicon, Inc., Internacional Farmacéutica, Medtronic Plc, Péters Surgical, Riverpoint Medical and other companies.

The lead analyst commented that "The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the market growth."

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

Read

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

Read

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

Read

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever